Stockreport

FDA Approves Ionis Pharmaceuticals' Rare Genetic Disease Therapy to Lower High-Level Of Fat In Blood [Yahoo! Finance]

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com
PDF On Thursday, the FDA approved Ionis Pharmaceuticals, Inc.'s (NASDAQ: IONS ) Tryngolza (olezarsen) as an adjunct to diet to reduce triglycerides in adults with familial [Read more]